Pioneer Group
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
NunaBio raises £6.5m led by Northstar Ventures to manufacture high fidelity synthetic DNA at scale
NunaBio develops an enzymatic DNA synthesis platform that manufactures high fidelity synthetic DNA at scale. The platform enables customers in sectors such as medicine, biotechnology and diagnostics to access complex DNA formats that are difficult to produce using traditional methods.
NuVision Biotherapies unlocks £4.8m in funding led by Mercia Ventures to speed up the healing of eye conditions
NuVision Biotherapies develops ophthalmic products based on amniotic membrane tissue. Its treatments are used to support healing after eye surgery and manage chronic eye conditions.
ImmuONE raises £600k follow-on from investors to expand 3D lung model as an alternative to animal testing
ImmuONE provides a 3D human lung laboratory model that replaces animal testing, allowing companies to assess respiratory safety, inflammation and long-term effects of chemicals, drugs and consumer products more reliably.
More venture news
- 5 Aug 2026
VisaDocVisaDoc secures a six-figure investment from Mercia to automate the visa process for business travellers
EquityLegal - 6 Aug 2026
Naked EnergyNaked Energy raises £9m led by Great British Energy to open a UK factory for its solar-thermal panels
EquityEnergy - 5 Aug 2026
Sorted TechnologiesSorted Technologies raises £920k in funding from Green Angel Ventures and Archipelago Ventures for low-cost robotics that automate waste sorting in recycling facilities
EquityIndustrial
